Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927691 · ClinicalTrials.gov registry record · Phase 2
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
A Phase 2 study, sponsored by Teachers College, Columbia University.
- Completed
- Registry status
- Phase 2
- Development phase
- 65
- Enrollment target
NCT02927691 is a Phase 2 study that has completed, run by Teachers College, Columbia University. The registered enrollment target is 65 participants.
The verdict
NCT02927691, a Phase 2 study, has completed, sponsored by Teachers College, Columbia University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 65 participants
- Enrollment target
Study Summary
Currently, there are no efficacious behavioral treatment approaches to address uncompensated aspiration, or aspiration without appropriate cough response, in Parkinson's disease (PD). This is of particular public health concern given that aspiration pneumonia is the leading cause of death in persons with PD. The overarching aim of the proposed study is to determine the efficacy of two distinct intensive rehabilitation paradigms, expiratory muscle strength training (EMST) and sensorimotor treatment for airway protection (smTAP), on airway protective clinical outcomes in persons with PD and dysphagia. The investigators anticipate the results will lead to reductions in the risks associated with airway protective deficits.
Interventions
- DEVICE EMST
- BEHAVIORAL smTAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2016-09 |
| Est. Completion | 2021-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02927691
The ClinicalTrials.gov registry entry for NCT02927691 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teachers College, Columbia University, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EMST is the first listed.
NCT02927691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02927691 about?
NCT02927691 is a clinical study titled "Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial". Currently, there are no efficacious behavioral treatment approaches to address uncompensated aspiration, or aspiration without appropriate cough response, in Parkinson's disease (PD). This is of particular public health concern given that aspiration pneumonia is the leading cause of death in persons...
What is the current status of trial NCT02927691?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 65 participants. The study started on 2016-09. Estimated completion is 2021-06.
What interventions are being tested in trial NCT02927691?
The interventions under investigation include: EMST (DEVICE), smTAP (BEHAVIORAL).
Who is sponsoring clinical trial NCT02927691?
This trial is sponsored by Teachers College, Columbia University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.